Consolidated figures
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin % | 68.4% | 49.9% | 33% | 58% |
| EBITDA margin % | 25.3% | 17.7% | -32.7% | 2.1% |
| EBIT margin % | 18.9% | 10.9% | -50.9% | -16.9% |
| PAT margin % | 17.2% | 14.4% | -38.6% | -7.5% |
| Working capital | ||||
| Receivable days | 113 | 52 | 127 | 204 |
| Inventory days | 649 | 228 | 318 | 550 |
| Payable days | 87 | 37 | 30 | 157 |
| NWC days | 676 | 243 | 416 | 597 |
| Leverage | ||||
| Current ratio | 2.57 | 8.8 | 8.63 | 2.62 |
| Debt to EBITDA | 1.84 | 0 | — | 14.96 |
| Debt to equity | 0.27 | 0 | 0 | 0.12 |
| Interest coverage | 9.4 | 17.7 | -39.8 | -4 |
| Asset turnover | 0.38 | 0.42 | 0.24 | 0.28 |
| Return ratios | ||||
| Return on assets % | 6.6% | 6.1% | -9.3% | -2.1% |
| Return on capital employed % | 13.5% | 12.8% | -9.4% | -2.6% |
| Return on equity % | 9.9% | 6.9% | -10.2% | -2.8% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.